AI assistant
Sending…
Q/C TECHNOLOGIES, INC. — Director's Dealing 2025
Apr 18, 2025
35313_dirs_2025-04-18_98141fa3-c65e-4f01-8a64-02a2e243cdcd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TNF Pharmaceuticals, Inc. (TNFA)
CIK: 0001321834
Period of Report: 2025-04-17
Reporting Person: RAUCH GARY M (Vice President, Finance)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-04-17 | Employee Stock Option (Right to Buy) | $0.1832 | A | 75000 | Acquired | 2035-04-16 | Common Stock (75000) | Direct |
Footnotes
F1: The stock options are subject to expiration if the employment of the Reporting Person is terminated.
More from Q/C TECHNOLOGIES, INC.
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 29
Annual Report
2026
Apr 15
Regulatory Filings
2026
Feb 11
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Regulatory Filings
2026
Jan 23
Regulatory Filings
2025
Dec 9
Regulatory Filings
2025
Dec 1
Regulatory Filings
2025
Dec 1